XPeng Analyst Price Targets - Benzinga

XPeng Inc

XPEVNYSE

Trade with Public

Trade with Public

$11.17

-0.19-1.67%

가까이에: Aug 31, 5:00 PM EST

$11.10

-0.26-2.29%

프리마켓: 6:32 AM EST

개요 뉴스 실적 전망 이벤트목표가재무 심리 비교 옵션 주식 보고서

XPeng Analyst Price Targets

Wall Street analyst price targets and consensus rating for XPeng (XPEV).

Price Target Range — 11 Quarters

Analyst Consensus — 10 Analysts

7Buy

2Hold

1Sell

Consensus RatingBuy# Analysts10Avg. Consensus PT$20Upside to Avg. PT+83.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2026	Barclays	Jiong Shao	PT Cut	Underweight	$15→$14
Aug 25, 2026	JP Morgan	Nick Lai	PT Cut	Overweight	$27→$24
Jul 16, 2026	Barclays	Jiong Shao	PT Cut	Underweight	$16→$15
May 29, 2026	Macquarie	Eugene Hsiao	Upgrade	Neutral→Outperform	$19
Mar 24, 2026	Barclays	Jiong Shao	PT Cut	Underweight	$17→$16
Mar 23, 2026	Macquarie	Eugene Hsiao	Downgrade	Outperform→Neutral	$24→$19
Jan 6, 2026	Freedom Broker	Roman Lukianchikov	Upgrade	Hold→Buy	$20→$25
Aug 20, 2025	Citigroup	Jeff Chung	PT Raise	Buy	$29→$29
Aug 19, 2025	B of A Securities	Ming Hsun Lee	PT Raise	Buy	$25→$26
Aug 15, 2025	Macquarie	Eugene Hsiao	PT Raise	Outperform	$24→$25
Jul 21, 2025	Freedom Broker	Roman Lukianchikov	PT Raise	Hold	$17→$20
May 22, 2025	Macquarie	Eugene Hsiao	Upgrade	Neutral→Outperform	$24
May 21, 2025	B of A Securities	Ming Hsun Lee	PT Raise	Buy	$27→$29
Mar 20, 2025	Barclays	Jiong Shao	PT Raise	Underweight	$7→$20
Mar 19, 2025	JP Morgan	Nick Lai	PT Cut	Overweight	$35→$31
Mar 19, 2025	B of A Securities	Ming Hsun Lee	PT Raise	Buy	$19→$27
Mar 18, 2025	Freedom Broker	Roman Lukianchikov	PT Raise	Hold	$12→$17
Mar 10, 2025	Citigroup	Jeff Chung	Upgrade	Neutral→Buy	$14→$29
Feb 24, 2025	UBS	Paul Gong	Upgrade	Sell→Neutral	$9→$18
Feb 7, 2025	Macquarie	Eugene Hsiao	Downgrade	Outperform→Neutral	$18

More with Benzinga EdgeGet Access

Analyst Ratings News

MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts changed outlook on top names: Piper raised $INTU price target, Ascendiant raised $QUBT target, BTIG cut $DKS target, HC raised $ZYME target, Needham increased $JAZZ target, Bernstein cut $MSTR target, Barclays raised $MDB target, UBS raised $SMTC target.

Avi Kapoor

PRO
Barclays Maintains Underweight on XPeng, Lowers Price Target to $14

Barclays analyst Jiong Shao maintains XPeng (NYSE:XPEV) with a Underweight and lowers the price target from $15 to $14.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on XPeng, Lowers Price Target to $24

JP Morgan analyst Nick Lai maintains XPeng (NYSE:XPEV) with a Overweight and lowers the price target from $27 to $24.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on XPeng, Lowers Price Target to $15

Barclays analyst Jiong Shao maintains XPeng (NYSE:XPEV) with a Underweight and lowers the price target from $16 to $15.

Benzinga Newsdesk

PRO
Macquarie Upgrades XPeng to Outperform, Maintains Price Target to $19

Macquarie analyst Eugene Hsiao upgrades XPeng (NYSE:XPEV) from Neutral to Outperform and maintains the price target from $19 to $19.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on XPeng, Lowers Price Target to $16

Barclays analyst Jiong Shao maintains XPeng (NYSE:XPEV) with a Underweight and lowers the price target from $17 to $16.

Benzinga Newsdesk